Holen Sie sich die Stockscreener-App
50.54
0.12%
0.06
Handel nachbörslich:
50.54
Supernus Pharmaceuticals Inc Aktie (SUPN) Neueste Nachrichten
Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run? - MSN
Supernus Pharmaceuticals, Inc. (SUPN) Stock forecasts - Yahoo Finance UK
Supernus Pharmaceuticals Inc (S49.DU) stock price, news, quote and history - Yahoo Finance UK
Understanding the Setup: (SUPN) and Scalable Risk - news.stocktradersdaily.com
Supernus Pharma Insider Sells $5.4 Million as Stock Surges 53% in a Year - aol.com
Hennion & Walsh Asset Management Inc. Has $4.01 Million Position in Supernus Pharmaceuticals, Inc. $SUPN - MarketBeat
Tudor Investment Corp ET AL Makes New Investment in Supernus Pharmaceuticals, Inc. $SUPN - MarketBeat
Supernus Pharmaceuticals, Inc. $SUPN Stock Holdings Lowered by JPMorgan Chase & Co. - MarketBeat
Market Trends: Is now the right time to enter Supernus Pharmaceuticals IncWall Street Watch & High Yield Equity Trading Tips - baoquankhu1.vn
Vanguard disaggregates holdings after internal realignment (SUPN) - Stock Titan
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Given Consensus Rating of "Hold" by Analysts - MarketBeat
D&O policy doesn’t cover antitrust suit over drug acquisition: Court - businessinsurance.com
Supernus Pharmaceuticals (NASDAQ:SUPN) Shares Pass Above 200-Day Moving AverageWhat's Next? - MarketBeat
Insurer Need Not Cover Parkinson's Drug Antitrust Dispute - Law360
Jefferies reiterates Supernus Pharmaceuticals stock Buy rating By Investing.com - Investing.com South Africa
Jefferies reiterates Supernus Pharmaceuticals stock Buy rating - Investing.com UK
Breakout Watch: What is the target price for Supernus Pharmaceuticals Inc stockQuarterly Growth Report & Low Volatility Stock Suggestions - baoquankhu1.vn
SUPN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
The Technical Signals Behind (SUPN) That Institutions Follow - news.stocktradersdaily.com
SUPN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SUPN Technical Analysis & Stock Price Forecast - Intellectia AI
Quarterly Risk: Does Supernus Pharmaceuticals Inc have strong EBITDA margins2026 Technicals & High Accuracy Buy Signal Tips - baoquankhu1.vn
Insider Selling: Supernus Pharmaceuticals (NASDAQ:SUPN) VP Sells 7,250 Shares of Stock - MarketBeat
Supernus Pharmaceuticals (NASDAQ:SUPN) VP Sells $2,514,000.00 in Stock - MarketBeat
[Form 4] SUPERNUS PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Supernus Pharmaceuticals Q4 2025 earnings preview - MSN
SUPN (NASDAQ: SUPN) Form 144 lists 57,250-share resale after option exercise - Stock Titan
SUPN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Supernus Pharmaceuticals CEO Sells $1.76M in Stock - National Today
Insider Sell Alert: Frederick Hudson Sells Shares of Supernus Ph - GuruFocus
[144] SUPERNUS PHARMACEUTICALS, INC. SEC Filing - Stock Titan
Supernus (NASDAQ: SUPN) CEO-linked KBT Trust sells 35,000 shares under 10b5-1 plan - Stock Titan
Director at Supernus (NASDAQ: SUPN) sells 5,369 shares - Stock Titan
SUPN SEC FilingsSupernus Pharma 10-K, 10-Q, 8-K Forms - Stock Titan
Assessing Supernus Pharmaceuticals (SUPN) Valuation After Recent Mixed Short And Long Term Returns - simplywall.st
Aristotle Capital Boston LLC Sells 503,122 Shares of Supernus Pharmaceuticals, Inc. $SUPN - MarketBeat
Insider sale of 5,369 shares at SUPN (NASDAQ: SUPN) - Stock Titan
Supernus Pharmaceuticals Stock Review: Valuation & Business Quality ConcernsNews and Statistics - IndexBox
3 Reasons SUPN is Risky and 1 Stock to Buy Instead - Yahoo Finance
Supernus at Barclays Conference: Strategic Growth and Future Prospects By Investing.com - Investing.com Canada
To promote Zurzuvae, Biogen and Supernus are Turning Tides against postpartum depression - Medical Marketing and Media
Supernus Pharmaceuticals, Inc. $SUPN Shares Acquired by Jefferies Financial Group Inc. - MarketBeat
Dimensional Fund Advisors LP Lowers Holdings in Supernus Pharmaceuticals, Inc. $SUPN - MarketBeat
Supernus (NASDAQ: SUPN) CEO exercises performance units, withholds shares for taxes - Stock Titan
Supernus (SUPN) SVP Mottola sells shares after exercising 3,750 PSUs - Stock Titan
SUPERNUS (NASDAQ: SUPN) CFO exercises performance units, settles taxes in shares - Stock Titan
Supernus (NASDAQ: SUPN) SVP sells 8,877 shares after exercising 7,500 PSUs - Stock Titan
[Form 3] SUPERNUS PHARMACEUTICALS, INC. Initial Statement of Beneficial Ownership - Stock Titan
Precision Trading with Supernus Pharmaceuticals Inc. (SUPN) Risk Zones - Stock Traders Daily
Supernus Pharmaceuticals, Inc. $SUPN Shares Sold by Victory Capital Management Inc. - MarketBeat
Victory Capital Management Reduces Stake in Supernus Pharmaceuticals - National Today
1.35%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):